Filing Details
- Accession Number:
- 0001209191-21-024226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 18:14:08
- Reporting Period:
- 2021-03-30
- Accepted Time:
- 2021-04-01 18:14:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1807120 | Design Therapeutics Inc. | DSGN | Pharmaceutical Preparations (2834) | 823929248 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849216 | Justin Thacker | C/O Design Therapeutics, Inc. 6005 Hidden Valley Road, Suite 110 Carlsbad CA 92011 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-30 | 17,500 | $20.00 | 17,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
